Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
National Resh Corp (NRC) delivers actionable healthcare experience insights through advanced analytics and proprietary methodologies. This news hub provides investors and industry professionals with essential updates on strategic initiatives shaping patient care innovation.
Access real-time press releases covering earnings disclosures, partnership announcements, and operational developments. Our curated feed simplifies tracking NRC's progress in transforming healthcare interactions through data-driven solutions.
Discover updates on key focus areas including patient engagement metrics, employee experience enhancements, and analytics platform innovations. Content is organized chronologically for efficient monitoring of NRC's market position and industry leadership.
Bookmark this page for streamlined access to verified NRC developments. Combine our updates with Stock Titan's financial tools to analyze the company's performance in healthcare experience optimization.
NRC Health's recent study reveals a significant disparity in trust levels between local healthcare providers and government entities during the COVID-19 pandemic. The research indicates that patients' language preferences notably influence their trust in healthcare providers, with English speakers 29% more likely to express strong trust. Additionally, trust in local healthcare systems rose from 20.7% to 35.8% from April 2020 to August 2022, while federal trust waned. Notably, trust levels are politically mixed across U.S. counties, challenging the narrative that political affiliation heavily influences provider trust.
On October 19, 2022, National Research Corporation (NASDAQ: NRC) announced an online web simulcast for its third quarter earnings conference call, scheduled for November 2, 2022, at 11:00 a.m. ET. The earnings results will be released after market close on November 1, 2022. A live audio webcast will be accessible via their website, with a replay available for 30 days after the event. NRC has a longstanding commitment to enhancing healthcare experiences through its proprietary methods and holistic approach.
NRC Health, a leader in personalized healthcare solutions, has announced its sponsorship of the Creative Learning Event Series organized by the Society for Participatory Medicine (SPM). This year-long initiative aims to enhance patient-provider relationships and promote equity in healthcare. The first event will be held on October 20, 2022, in Boston, focusing on access to care in underserved communities. NRC Health's support aligns with its mission of achieving Human Understanding, emphasizing collaboration among patients and healthcare professionals.
NRC Health announced a quarterly cash dividend of $0.24 per share, payable on October 14, 2022, to shareholders on record by September 30, 2022. This decision reflects NRC Health's ongoing commitment to returning value to its investors. With over 40 years of experience, NRC Health focuses on enhancing healthcare experiences and building trust within organizations through innovative methods and skilled associates.
NRC Health announced the winners of its 2022 Consumer Loyalty Awards and Excellence in Patient Experience Awards. This year, top hospitals were acknowledged for exceptional patient experiences amidst ongoing healthcare challenges post-pandemic. The Consumer Loyalty Awards spotlighted the top 100 healthcare facilities focusing on cultivating long-lasting loyalty, with ten facilities designated as Best-In-Class. The Excellence in Patient Experience Awards recognized hospitals for their commitment to improving patient care, based on Net Promoter Scores from patient surveys.
NRC Health announced its new role as a Diamond Supporting Partner with The Beryl Institute, emphasizing a commitment to enhancing patient experience through collaboration. This partnership aims to provide resources and opportunities for healthcare organizations to better serve patients. Helen Hrdy, Chief Growth Officer, underscored the critical need for patient-centered care. NRC Health has actively supported The Beryl Institute through past events and will now contribute to expanding the community's content and access to resources for members globally.
On August 2, 2022, National Research Corporation (NASDAQ:NRC) reported a 2% increase in Q2 2022 revenue, totaling $37.3 million, compared to $36.4 million in Q2 2021. However, operating income fell by 6% to $11.5 million, with net income decreasing to $8.3 million from $8.9 million. Diluted earnings per share also declined to $0.33. The company secured its first contract for the Human Understanding Program with Novant Health and continues to prioritize organic growth, despite challenges from discontinued offerings impacting revenue growth.
National Research Corporation (NASDAQ:NRC) will host a web simulcast of its Q2 2022 earnings conference call on August 3, 2022, following the market close on August 2, 2022, when the earnings results will be released. The live broadcast starts at 11:00 a.m. ET and will be available for replay for 30 days. NRC has over 40 years of experience in enhancing healthcare through Human Understanding, helping organizations improve customer experiences and trust.
NRC Health announced a quarterly cash dividend of $0.24 per share payable on July 15, 2022, to shareholders on record by June 30, 2022. Additionally, the Board of Directors approved a new stock repurchase authorization of up to 2.5 million shares. This buyback will occur based on market conditions and corporate considerations. The previous repurchase authorization has concluded, and the new one has no expiration date, reflecting NRC Health's commitment to enhancing shareholder value.
FAQ
What is the current stock price of National Resh (NRC)?
What is the market cap of National Resh (NRC)?
